Following CORDStrom TM, INmune Bio plans to transition production of INKmune ®, its NK-priming cell medicine for solid tumors, to the same facility, supporting ongoing and future trials in the US and ...

SynOx Therapeutics Limited (“SynOx”), a late-stage clinical biopharmaceutical company developing of emactuzumab for Tenosynovial Giant Cell Tumours (TGCT), today announced that the United States Food ...

Four leading companies CTMC, Iovance Therapeutics, KSQ, and TILT Biotherapeutics prognosticate coming successes of new technology approaches to better tumor-infiltrating lymphocyte activities.

Researchers at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S.

Intel revives and redefines its iconic 'Intel Inside' campaign with the new slogan 'That's the power of Intel Inside. ' The ...

Cell polarity is the asymmetric organisation of several cellular components, including its plasma membrane, cytoskeleton or organelles. This asymmetry can be used for specialised functions, such ...

Max, formerly known as HBO Max, officially has a new logo on Sunday night ... Then-global CMO Patrizio Spagnoletto told AdWeek that the company felt blue was best. “There’s different types ...

The cell has been established based on the concept of 'Ease of Doing Business' to streamline industrial operations. The primary objective of the cell is to establish effective communication ...

This award is dedicated to the entire Rallye Acura team who worked hard to make it possible,” explains Rallye Motor Company General ... push towards hydrogen fuel cells and other “greenwashing ...

The company later reduced the number of eligible countries to four, but the US remained among those continuing the beta. The One UI 7 Beta 6, recently released for the Galaxy S24, shows that the ...

Lady Gaga was hit with a $100 million lawsuit by a California surf company over claims the pop star stole their logo for her new merchandise, according to documents obtained by FOX Business.

Dr. Kristina Kusche-Vihrog, head of the Institute of Physiology at the University of Lübeck, speaks about the nanomechanics of living cells and their implications for cardiovascular disease.